Wellcome Diagnostics
Country not established
- Devices
- 28
What Wellcome Diagnostics makes
Wellcome Diagnostics makes diagnostic kits and tests, including those for detecting influenza, bacterial antigens, strep, and other infectious diseases. Their products include the WELLCOGEN H. INFLUENZAL ZL21, WELLCOGEN BACTERIAL ANTIGEN KIT, and STREPTEX DIRECT A ZL14, among others. These devices are used to diagnose various conditions, such as meningitis and rotavirus. The company's portfolio also includes tests for detecting specific antibodies and antigens, like the MENINGOCOCCUS GROUP B MONOCLONAL ANTIBODY ZM-51.
The company's devices are classified as Class I and Class II, and are listed in the FDA 510(k) registry. Wellcome Diagnostics is based in the US.
Catalogue
Search and filter all 28 devicesFrequently asked questions
How many devices does Wellcome Diagnostics have in the registry?
The registry currently lists 28 devices for Wellcome Diagnostics. Devices recorded under merged duplicate company entries are counted once.
Which registries list Wellcome Diagnostics's devices?
Among its 28 most recently registered devices, Wellcome Diagnostics has devices listed in FDA 510(k) (28 devices).
What risk classes do Wellcome Diagnostics's devices fall under?
Among its 28 most recently registered devices, the classes recorded for Wellcome Diagnostics's devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Wellcome Diagnostics in the registry?
The most recently registered devices listed for Wellcome Diagnostics include STREPTEX ACID EXTRACTION KIT, WELLCOGEN H. INFLUENZAL ZL21, WELLCOGEN BACTERIAL ANTIGEN KIT and FIBRI-PREST AUTOMATE HA34.